Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Embecta Corp (EMBCV)

Embecta Corp (EMBCV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 1,165 M
  • Annual Income, $ 415,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.63
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade EMBCV with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Most Recent Stories

More News
Why Embecta Stock Is Tanking Today

There was good news and bad news with the diabetes care company's fiscal Q1 update.

EMBCV : 33.33 (-8.48%)
3 Top Dividend Kings to Buy for the Long Haul

These healthcare stocks all have above-average dividends.

EMBCV : 33.33 (-8.48%)
JNJ : 146.34 (-0.33%)
ABBV : 159.43 (-4.70%)
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential

These three spinoffs are already profitable.

EMBCV : 33.33 (-8.48%)
VTRS : 11.62 (+1.31%)
GEHC : 86.49 (+0.63%)
BDX : 232.02 (+0.67%)
PFE : 25.49 (+0.91%)
GE : 162.73 (+0.91%)
Why Embecta Stock Popped by Nearly 13% Today

Twin beats and raised guidance make for a good day on the market for the diabetes care specialist.

EMBCV : 33.33 (-8.48%)
BDX : 232.02 (+0.67%)
Why Embecta Stock Is Sinking Today

Investors didn't like the diabetes care provider's Q4 update.

EMBCV : 33.33 (-8.48%)
embecta Announces Earnings Conference Call Information for the Third Quarter of Fiscal Year 2022

PARSIPPANY, N.J., July 05, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (NASDAQ: EMBC), one of the largest pure-play diabetes care companies in the...

EMBCV : 33.33 (-8.48%)
EMBC : 10.33 (-0.67%)
Embecta Corp. Reports Second Quarter and First Six Months of Fiscal Year 2022 Financial Results and Provides Financial Guidance for the Last Six Months of Fiscal Year 2022

PARSIPPANY, N.J., May 13, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the...

EMBCV : 33.33 (-8.48%)
EMBC : 10.33 (-0.67%)
embecta Announces Second Quarter 2022 Earnings Conference Call Information

FRANKLIN LAKES, N.J., April 19, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (NASDAQ: EMBC) today announced that it will report its financial results...

EMBCV : 33.33 (-8.48%)
EMBC : 10.33 (-0.67%)
embecta completes spin-off from BD and lists on NASDAQ as a global leader in diabetes care

100-year legacy in insulin delivery Largest producer of diabetes injection devices in the world Over 2,000 employees globally serving more than 100...

EMBCV : 33.33 (-8.48%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar